|1.||Adamo, Joan E: 1 article (11/2009)|
|2.||Weir, Jerry P: 1 article (11/2009)|
|3.||Merchlinsky, Michael J: 1 article (11/2009)|
|4.||Meseda, Clement A: 1 article (11/2009)|
|5.||Saijo, Masayuki: 1 article (03/2009)|
|6.||Saito, Tomoya: 1 article (03/2009)|
|7.||Kanatani, Yasuhiro: 1 article (03/2009)|
|8.||Kuwabara, Noriyuki: 1 article (03/2009)|
|9.||Fujii, Tatsuya: 1 article (03/2009)|
|10.||Takeuchi, Tsutomu: 1 article (03/2009)|
03/11/2009 - "Administration of an attenuated tissue-cultured smallpox vaccine (LC16m8) to healthy adults was associated with high levels of vaccine take and seroconversion in those who were vaccinia-naive and yielded an effective booster response in some previously vaccinated individuals."
03/11/2009 - "The attenuated, tissue-cultured, third-generation smallpox vaccine LC16m8 was administered to vaccinia-naive infants in Japan during the 1970s without serious adverse events. "
11/01/2009 - "Human vaccinia immune globulin was used to screen the secreted proteins from cells infected with Dryvax or the candidate smallpox vaccine LC16m8 to determine whether the protective humoral response included antibodies against secreted viral proteins. "
|2.||Proteins (Proteins, Gene)